[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Infection Prevention for Multiple Myeloma Patients with Dr. Benjamin Derman

Infection Prevention for Multiple Myeloma Patients with Dr. Benjamin Derman image

Infection Prevention for Multiple Myeloma Patients with Dr. Benjamin Derman

Relapsed/Refractory Myeloma
event May 25, 2022 / 12:00PM - 01:00PM EDT
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Myeloma patients need to be vigilant due to their immunocompromised status. After fighting myeloma and achieving a remission, many patients continue to worry about other infections or diseases that might come their way. What preventions should be taken to prevent infection? How can patients enjoy a high quality of life while still being cautious or protective? Hear Dr. Derman's opinion on the subject and ask your questions.

Schedule & Agenda

person
Introduction
12:00PM
Audrey Burton-Bethkee
Audrey introduces the agenda of the event and featured speaker Dr. Benjamin Derman.
person
Presentation
12:05PM
Dr. Benjamin Derman
Dr. Benjamin Derman talks about what preventions should be taken to prevent infection, and how can patients enjoy a high quality of life while still being cautious or protective.
person
Questions and Answers
12:35PM
Audience
Type your questions in the chat and we will answer them!

Speakers & Moderators

The panelist Audrey Burton-Bethke
Audrey Burton-Bethke

Audrey joined the HealthTree Foundation as the Myeloma Community Program Director in 2020. While not knowing much about myeloma at the start, she has since worked hard to educate herself, empathize and learn from others' experiences. She loves this job. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.

Read Bio
The panelist Benjamin Derman, MD
Benjamin Derman, MD

Benjamin Derman, MD, specializes in hematology and oncology. Dr. Derman is an expert in multiple myeloma and other plasma cell disorders, such as monoclonal gammopathy, amyloidosis, plasmacytoma, and POEMS syndrome. He also diagnoses and treats cancerous conditions and uses the most innovative techniques, including CAR T-cell therapy and stem cell transplantation to deliver long-term success for his patients. Along with his clinical practice, Dr. Derman remains committed to research. Currently, he is focused on identifying strategies that can lead to a possible cure for multiple myeloma, including using very sensitive tests that measure small amounts of residual cancer cells in the body called ‘minimal residual disease’ (MRD) to guide decision making. Dr. Derman is also investigating new methods and therapies designed to improve outcomes and quality of life for his patients. Additionally, he is interested in evaluating reasons for racial disparities in multiple myeloma outcomes to better understand and care for those patients. His work has been published in several peer-reviewed journals, including the Journal of Immunotherapy of Cancer, Blood, Blood Advances, Blood Cancer Journal, Leukemia and Lymphoma and British Journal of Haematology.

Read Bio

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

newsletter icon

Get the latest thought leadership on your Acute Myeloid Leukemia delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.

Thanks to our HealthTree Community for Acute Myeloid Leukemia Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Genentech
Regeneron
Adaptive

Follow Us

facebook instagram youtube